Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Chicken B-Cell Lymphoma 2 (BCL-2) Monoclonal Antibody

Cat. No.VD8N22

Product TypeAnimal-targeted Antibodies

Size

Product Overview

BioVenic mouse monoclonal antibody is specific for chicken B-cell lymphoma 2. It can be applied to IF, ICC, WB and IHC assays of chicken B-cell lymphoma 2.

Specifications

Application IF; ICC; WB; IHC
Clonality Monoclonal
Classification Primary Antibody
Clone G2N22
Host Mouse
Target Species Chicken
Species Reactivity Chicken
Specificity Chicken B-Cell Lymphoma 2
Isotype IgG
Immunogen Synthetic peptide of B-cell lymphoma 2
Concentration 1 mg/mL
Conjugation Unconjugated
Physical State Liquid

Target Information

Chicken BCL-2, known as B-cell lymphoma 2 in chickens, is an anti-apoptotic protein that belongs to the BCL-2 family, which is essential in the regulation of programmed cell death, or apoptosis. This protein functions by inhibiting the release of cytochrome c from mitochondria, thereby preventing the activation of caspases, the enzymes that execute the apoptotic process. BCL-2's overexpression is associated with cell survival, while its downregulation or the imbalance with pro-apoptotic family members like Bax can lead to cell death.

Target Chicken B-Cell Lymphoma 2
Target Synonym BCL2; Apoptosis regulator Bcl-2
Gene ID 396282
UniProt ID Q00709

Shipping and Storage

This product is shipped with ice gel packs. Store at -20°C (up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Alam, Manzar, et al. "B cell lymphoma 2: a potential therapeutic target for cancer therapy." International journal of molecular sciences 22.19 (2021): 10442.
Inquiry Basket